All In MedTech

FDA Clearance Tracker · P200035-S007

OrganOx metra® System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 20, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 20, 2023

Approved

Time to decision

276 days

Received Feb 17, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P200035-S007
Device name
OrganOx metra® System
Applicant location
Oxford
Received
Feb 17, 2023
Decided
Nov 20, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P200035

Device type

Device class
Class III

Every decision under product code QQK

FDA's approval statement

As written in FDA's record.

This 180-day PMA supplement requested approval for changes to the hardware and software of the OrganOx metra Retained Unit (Part Number D0003). These changes include the update of hardware components due to obsolescence and to facilitate electrical safety and electromagnetic compatibility (EMC) testing compliance. In addition, the software Operating System (OS) is updated from Windows 7 to Windows 10 and the Graphical User Interface (GUI) component of the system software is updated to accommodate the update to Windows 10 operating system.

Source documents

Other decisions for Organox Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.